Parallax Volatility Advisers’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$1.18M 2987
2023
Q1
$384K Buy
100,000
+32,847
+49% +$140K ﹤0.01% 1811
2022
Q4
$333K Buy
+67,153
New +$364K ﹤0.01% 2013
2022
Q3
Sell
-76,016
Closed -$401K 3476
2022
Q2
$342K Buy
76,016
+37,516
+97% +$163K ﹤0.01% 2049
2022
Q1
$183K Buy
+38,500
New +$213K ﹤0.01% 2214
2019
Q2
Sell
-125,667
Closed -$341K 3976
2019
Q1
$341K Buy
+125,667
New +$544K ﹤0.01% 1667
2018
Q4
Sell
-28,385
Closed -$269K 4185
2018
Q3
$269K Buy
+28,385
New +$273K ﹤0.01% 1560
2018
Q1
Sell
-15,246
Closed -$98K 4614
2017
Q4
$98K Buy
+15,246
New +$94K ﹤0.01% 2823

Other funds holding IMGN

Parallax Volatility Advisers's IMGN Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.18M sold.

Parallax Volatility Advisers first reported a position in IMGN in Q4 2017 and held it in 7 quarters. The position peaked at $384K in Q1 2023. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 100,000 Immunogen Inc shares in Q2 2023, an estimated $1.18M.
  • Parallax Volatility Advisers first reported a position in Immunogen Inc in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Immunogen Inc position peaked at $384K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.